Alterations in brain dopamine and GABA following inorganic or organic manganese administration

Area of Science:

• Neuroscience
• Toxicology
• Environmental Health

Background:

• Manganese is an essential element, but excessive exposure can lead to neurotoxicity.
• Previous studies have indicated that inorganic manganese can affect neurotransmitter systems.

Purpose of the Study:

• To investigate the neurochemical effects of chronic exposure to inorganic manganese (MnCl2) and an organic manganese fuel additive (MMT) in mice.
• To compare the impact of different forms and durations of manganese exposure on brain neurotransmitter concentrations.

Main Methods:

• Mice were administered MnCl2 in their diet for 6 months or MMT via injection for 3 weeks.
• Neurotransmitter levels (dopamine, GABA) and enzyme activity (choline acetyltransferase) were measured in specific brain regions (striatum, olfactory tubercles, cerebellum, substantia nigra).
• Acute and sub-chronic exposure groups were also included for comparison.

Main Results:

• Chronic administration of both MnCl2 and MMT led to decreased dopamine concentrations in the striatum and olfactory tubercles.
• Elevated GABA levels were observed in the striatum following both treatments, and in the substantia nigra after MMT exposure.
• No significant changes in choline acetyltransferase activity were detected.
• Neurotransmitter alterations were associated with long-term exposure, not acute or sub-chronic exposure.

Conclusions:

• Chronic exposure to manganese, whether inorganic or organic, can induce significant changes in brain neurotransmitter systems, particularly dopamine and GABA.
• These findings align with previous research on inorganic manganese toxicity and highlight the potential neurotoxic effects of MMT.
• The observed neurochemical changes underscore the importance of considering the duration and form of manganese exposure when assessing neurotoxic risk.